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Background: Computed tomography angiography (CTA) is frequently used with
computed tomography perfusion imaging (CTP) to evaluate whether endovascular
vasospasm treatment is indicated for subarachnoid hemorrhage patients with delayed
cerebral ischemia. However, objective parameters for CTA evaluation are lacking.
In this study, we used an automated, investigator-independent, digital method to
detect vasospasm, and we evaluated whether the method could predict the need for
subsequent endovascular vasospasm treatment.
Methods: We retrospectively reviewed the charts and analyzed imaging data for
40 consecutive patients with subarachnoid hemorrhages. The cerebrovascular trees
were digitally reconstructed from CTA data, and vessel volume and the length of the
arteries of the circle of Willis and their peripheral branches were determined. Receiver
operating characteristic curve analysis based on a comparison with digital subtraction
angiographies was used to determine volumetric thresholds that indicated severe
vasospasm for each vessel segment.
Results: The automated threshold-based volumetric evaluation of CTA data was
able to detect severe vasospasm with high sensitivity and negative predictive value
for predicting cerebral hypoperfusion on CTP, although the specificity and positive
predictive value were low. Combining the automated detection of vasospasm on
CTA and cerebral hypoperfusion on CTP was superior to CTP or CTA alone in
predicting endovascular vasospasm treatment within 24 h after the examination.
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Conclusions: This digital volumetric analysis of the cerebrovascular tree allowed the
objective, investigator-independent detection and quantification of vasospasms. This
method could be used to standardize diagnostics and the selection of subarachnoid
hemorrhage patients with delayed cerebral ischemia for endovascular diagnostics and
possible interventions.
Keywords: computed tomography angiography, computed tomography perfusion imaging, grading, vasospasm,
subarachnoid hemorrhage, delayed cerebral ischemia
INTRODUCTION
Spontaneous subarachnoid hemorrhage (SAH) is a subtype of
hemorrhagic stroke (1–3). In most cases, SAH is caused by the
rupture of an intracranial aneurysm, with the bleeding resulting
in a considerable increase in intracranial pressure. The resulting
decline in cerebral perfusion pressure then induces transient
global cerebral ischemia. Early brain injury can occur as an
immediate effect of the bleeding and the transient global cerebral
ischemia (4, 5). The intracranial pressure eventually decreases
and cerebral perfusion returns (5). Of the patients who survive
the initial bleeding event, up to 30% then suffer delayed cerebral
ischemia (DCI) during the first weeks after SAH (4, 5). DCI
is defined as a new global or focal neurological impairment
that lasts for at least 1 h or a new cerebral infarction that was
not immediately apparent after aneurysm occlusion and which
is attributable to ischemia and not to other causes (6). The
underlying pathophysiology of DCI is only partially understood.
However, it is accepted that its genesis is multifactorial, with
factors including vasospasms of the large intracranial arteries,
disturbance of the microcirculation by vasospasms and the
microthrombosis of microvessels, cortical spreading depression,
and inflammatory effects (4–7).
Endovascular interventions can be applied as rescue therapies
when patients experience severe vasospasms of the large
intracranial arteries that threaten to impair cerebral perfusion;
possible interventions include angioplasty of the spastic segments
or the intra-arterial administration of vasodilating drugs (6, 8–
12). The gold standard for the diagnosis of severe vasospasm
with an indication for endovascular intervention is digital
subtraction angiography (DSA), which allows an assessment
of the severity of the vasospasm and of its effects on the
perfusion of subsequent vascular territories (6, 8–10). However,
DSA is an invasive and technically demanding intervention
and so is not suitable as a screening tool. The indication
for DSA is therefore commonly based on a combination
of non- or less-invasive techniques, including a clinical
examination (if the patient is conscious), a transcranial Doppler
ultrasound examination of cerebral blood flow velocities, cerebral
perfusion computed tomography (CTP), and cerebral computed
tomography angiography (CTA) (6, 8–10).
Studies have shown that CTP can be used to detect
cerebral hypoperfusion and predict cerebral infarction (13–
18). A prospective observational study, however, reported that
CTP had a positive predictive value (PPV) of only 29% for
forecasting severe vasospasm or new cerebral infarction within
the subsequent 72 h (19). Other studies have shown that CTA
can detect cerebral vasospasms with a sensitivity and specificity
comparable to that of DSA (20–22). Therefore, CTA is commonly
regarded as offering a valuable adjunct to CTP for deciding
whether DSA and endovascular intervention are indicated.
However, although several studies have established objective
scores and defined thresholds for the evaluation of CTP (13–19),
there remains a lack of objective parameters or thresholds for the
interpretation of CTA.
One possible approach to standardizing the assessment of
CTA and exploiting additional diagnostic information is to
perform digital analyses of cross-sectional imaging data of the
cerebrovascular tree. This could potentially detect the extent of
the angiographic vasospasm and grade it automatically in an
investigator-independent manner. Our group has developed a
method that enables a highly accurate virtual reconstruction of
the intracranial vascular tree from CTA data and a volumetric
analysis of entire vessel segments (23). In a previous study,
we performed a volumetric evaluation of the M1 segment of
the middle cerebral artery based on CTA data acquired as
part of the DCI diagnostics for a cohort of SAH patients
(24). We determined a volumetric threshold that could predict
with moderate sensitivity and fair specificity the patients for
whom endovascular treatment would subsequently be indicated
(according to the diagnostic standards of our hospital) or
who would experience a new cerebral infarction within 72 h.
This demonstrated that such an assessment can identify severe
vasospasms. However, the study was limited by focusing
exclusively on the M1 segment.
In the present study, we extended the approach to an analysis
of all the vessel segments of the circle of Willis and their major
peripheral branches. This study had two aims: to determine
volumetric thresholds for each vessel segment as an objective
measure for diagnosing severe vasospasm; and to test whether
the automated detection of severe vasospasm by volumetric CTA
evaluation, alone or in combination with CTP, could be used to
predict the subsequent indication for endovascular vasospasm
treatment in this study cohort.
MATERIALS AND METHODS
Patients and Study Design
We performed a retrospective chart review and analysis of
imaging data from 40 consecutive SAH patients admitted to
our institution between November 2013 and December 2015
and who underwent surveillance for vasospasm. These patients
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were primarily enrolled in an unrelated prospective clinical study
of a diagnostic medical device conducted at our institution
(registered with ClinicalTrials.gov, identifier NCT02071875; the
study is yet to report). Characteristics of the patients are
summarized in Figures 1A–F.
All the procedures in this study were conducted in accordance
with the ethical standards of our institutional review board
(Ethikkommission der Landesaerztekammer Rheinland Pfalz),
which approved the study protocol, and with the principles of the
1964 Helsinki Declaration and its later amendments. Informed
consent was obtained from all the patients included in this study
or their legally authorized representative. The retrospective chart
review was also approved by our institutional review board.
Clinical Management
The SAH patients were managed clinically according to clinical
standard protocols described previously (24–26). In brief, the
SAH was diagnosed by cranial CT, followed by CTA and DSA to
detect aneurysms. After reaching an interdisciplinary consensus,
an aneurysm was treated either by surgical clipping or by
endovascular coil embolization with or without remodeling.
If indicated, cerebrospinal fluid drains were placed to treat
hydrocephalus. Multimodal neuromonitoring of intracranial
pressure and brain tissue oxygenation (ptiO2) was used for
sedated patients for whom a detailed neurological examination
was not feasible. All patients received oral nimodipine for 21 days
after the SAH. DCI was suspected when there was focal or global
neurological deterioration, a reduction in ptiO2 to <15 mmHg,
or increased Doppler sonographic blood flow velocities; blood
flow velocities of <120 cm/s were considered non-suspicious
for vasospasm, whereas those of >200 cm/s in at least one
intracranial vessel segment triggered further diagnostics. For
blood flow velocities that were between 120 and 200 cm/s, further
diagnostics were initiated upon the discretion of the responsible
neurointensivist, taking the course of blood flow velocities in
serial examinations into account. CTA and CTP were performed
with cases of suspected DCI. Cases of cerebral hypoperfusion that
were confirmed on CTP were treated by induced hypertension
aiming at a mean arterial pressure of >110 mmHg or a cerebral
perfusion pressure of >100 mmHg. DSA was performed only
in refractory cases (i.e., no improvement of neurological deficit
or no improvement in ptiO2 in the case of sedated patients), to
perform endovascular treatment (i.e., angioplasty and/or intra-
arterial vasospasmolysis with nimodipine). Only these DSAs were
evaluated in this study.
Data Collection
Data were extracted from charts on the patient’s sex, age, Hunt
and Hess (27) and Fisher (28) grades at hospital admission,
outcome at discharge, and localization of the symptomatic
aneurysm. CTA, CTP, and DSA imaging data were obtained
from the clinical imaging archive. All the data were collected in
anonymized files.
Imaging
CTA and CTP were performed according to standard diagnostic
protocols (80 kV; 50 mAs; 40mL Imeron 400 administered via
a power injector at an injection rate of 5 mL/s) using a Toshiba
Aquilion 32 CT scanner with 32 slices (512× 512 pixels; Software
Base V3.20◦R003//Appl.: V3.10GR004), as described previously
(24). Intracranial CTA was recorded from the foramen magnum
up to the superior sagittal sinus. The start of acquisition was
triggered manually at the moment of maximal contrast in the
aortic arch. Images were reconstructed in the axial, sagittal, and
coronal planes. The duration of the CTP scan was 45 s; four
brain segments were scanned with 30 layers in each, resulting in
120 images.
Catheter angiography was performed using standard
intraarterial biplane DSA (Biplane Allura Xper FD System,
Philips, The Netherlands). After placement of the femoral sheath
in the common femoral artery, cerebral DSA was performed,
including the circulation along the left and right internal carotid
arteries as well as in at least one vertebral artery. The DSA of the
cerebral vessels was documented in the standard projection and
oblique projections.
The CTA, CTP, and DSA images were reviewed using Sectra
Workstation IDS7 Software Version 18.2.8.3923 (Sectra AB,
Linköping, Sweden).
Volumetric Analysis of CTA Data
The CTA data sets acquired within the scope of the diagnostics
for DCI were subjected to a volumetric analysis of the intracranial
vessels using Amira software version 5.4.2 (FEI Visualization
Sciences Group, Hillsboro, OR, USA) following a standardized
protocol (23, 24). In brief, the bone was virtually subtracted and
the intracranial vascular tree was then virtually reconstructed by
applying a standardized windowing procedure (23, 24) shown to
have high interrater agreement in results for vessel volumes (24).
The vessel volume and the length of the corresponding vessel
segment were calculated according to a standardized algorithm,
as previously described (23, 24, 29, 30), for the following
vessel segments: the basilar artery, the posterior cerebral artery,
the internal carotid artery, the M1 and M2 segments of the
middle cerebral artery, and the A1 and A2 segments of the
anterior cerebral artery. To account for individual differences
in the length of the vessel segments, the vessel volumes were
expressed in relation to the vessel length (volume/length ratio).
The volume/length ratios of the PCAwere calculated considering
P1 and P2 segments together; in case of an atretic P1 segment
with fetal PCA (a single case), the PCA volume/length ratio was
calculated by only considering the P2 segment. Figures 1G, 2
provide a detailed overview of the vessel segments analyzed and
illustrate the volumetric analysis of a vessel segment.
Grading of Vasospasm
Vasospasm was diagnosed and graded for the present study by
an experienced neuroradiologist using the DSA data acquired
immediately after CTA and prior to any endovascular vasospasm
treatment. The neuroradiologist also had access to the DSA
performed at hospital admission to search for the bleeding
source, and to the corresponding CTA. She was blinded to all
other examinations. The neuroradiologist identified the vessel
segments of the circle of Willis and their major branches. Each
vessel segment was then graded according to a grading system
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FIGURE 1 | Patient characteristics and the vessel segments examined. (A–F) Characteristics of the patients included in the study. (G) The volumetrically evaluated
vessel segments.
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for vasospasms (13), as follows: 0, no vasospasm; 1, vasospasm
with <50% change in the vessel diameter compared to the
initial DSA; or 2, vasospasm with >50% narrowing of the vessel
diameter compared to the initial DSA. Vasospasms graded 2 were
considered severe. An example is shown in Figure 2.
Evaluation of CTP
CTP data acquired within the scope of the diagnostics for DCI
were evaluated for perfusion deficits using a visual grading
score developed by Wintermark et al. (15). The evaluation
was performed for the present study by an experienced
neuroradiologist blinded to the results of the volumetric
evaluation of CTA data. In brief, the neuroradiologist reviewed
the mean transit time and cerebral blood flow maps and graded
defined anatomical regions (frontal, temporal, parietal, and
occipital regions and the thalamus, basal ganglia, and insula)
for abnormality as follows: 0, the perfusion appeared normal; 1,
perfusion appeared abnormal. A grading other than 0 in at least
one of the analyzed regions was considered to indicate cerebral
hypoperfusion. An example is shown in Figure 2.
Statistical Analysis
We used R software version 3.4.1 (https://www.r-project.
org/) and the R packages “pROC” and “psych” for the
statistical evaluation.
Vessel Segment Volume Thresholds for Severe
Vasospasm
A threshold value that predicted severe vasospasm (i.e.,
vasospasm classified as 2) was established for each of the
vessel segments. The classifications of vasospasm in single vessel
segments on DSA were taken as the gold standard and used
in receiver operating characteristic (ROC) curve analyses of the
volumetric evaluations from the corresponding CTAs. The cutoff
values that maximized the sum of sensitivity and specificity for
each segment were identified (31). A bootstrap algorithm was
then applied to calculate the optimal threshold and its 95%
confidence interval based on 2,000 stratified bootstrap replicates
for each single vessel segment. Data for the left and right vessel
segments were analyzed together.
Diagnostic Value for Predicting Cerebral
Hypoperfusion
The volumetric CTA evaluation method was assessed for its
diagnostic value in predicting cerebral hypoperfusion, with the
presence of hypoperfusion on CTP used as the gold standard.
All CTA examinations performed together with CTP were used
in the analysis and the vessel segment thresholds (described in
the previous section) were applied to the vessel volumes. Three
different criteria were considered: a minimum of one vessel
segment was below the threshold on CTA; a minimum of two
vessel segments were below the threshold; or a minimum of three
vessel segments were below the threshold. Contingency tables
were created and the sensitivity, specificity, and positive and
negative predictive values (PPV, NPV) were calculated.
Diagnostic Value for Predicting Subsequent
Endovascular Vasospasm Therapy
The volumetric CTA evaluation, CTP, and the combination
of CTA and CTP were assessed for their diagnostic value for
predicting subsequent endovascular vasospasm therapy. The
aim was to assess whether volumetric CTA evaluation or CTP
alone, or the combination of both, could predict the presence
of vasospasm with impeding infarction if no endovascular
treatment is performed. The gold standard used as an indication
of the presence of severe vasospasm and impeding infarction was
that the patient underwent endovascular vasospasm treatment
(indicated according to the clinical standard of the hospital)
within 24 h of the CTA examination.
CTA was considered pathological if a minimum of one, two,
or three vessel segments were found to be below the respective
threshold. The evaluation of CTP for perfusion deficits was
considered pathological if it yielded a score of at least 1 point
(as described in section Evaluation of CTP). The combination
of CTP and CTA was considered pathological when both these
conditions were true. For each of these assessments, contingency
tables were created and the sensitivity, specificity, PPV, and NPV
were calculated.
RESULTS
Diagnosis of DCI With CTA, CTP, and DSA
A total of 110 CTA examinations for suspected DCI performed
during hospitalization were identified. Of these, nine CTA data
sets could not be analyzed digitally for technical reasons. Finally,
101 CTA data sets (for 33 patients) were subjected to the
volumetric evaluation.
Subsequent DSA for interventional vasospasm treatment was
available for 20 of the volumetrically evaluated CTA data sets
(for 10 patients). These 20 sets of CTA examinations and
corresponding DSAs were used to determine the thresholds for
severe vasospasm.
CTP examinations with corresponding cerebral blood flow
and mean transit time maps were available for 96 of the
volumetrically evaluated CTA data sets (for 33 patients).
These 96 sets of CTA examinations with corresponding
CTP were used to compare the volumetric CTA and CTP
evaluations and to determine their diagnostic value for predicting
subsequent endovascular vasospasm treatment. Within these, 19
examinations (for 10 patients) had been followed by DSAs for
endovascular vasospasm treatment within 24 h.
A flow chart summarizing patient and imaging data is shown
in the Supplementary Material.
Vessel Segment Volume Thresholds for
Severe Vasospasm
The 20 DSA data sets included 63 severe (i.e., grade 2)
vasospasms, located as follows: internal carotid artery, 8; M1
segment, 10; M2 segment frontal branch, 7; M2 segment
temporal branch, 12; A1 segment, 5; A2 segment, 11; posterior
cerebral artery, 5; and basilar artery, 5. We did not calculate
a specific threshold for the vertebral artery because of the
marked variability of individual diameters between sides and
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FIGURE 2 | Continued
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FIGURE 2 | Digital reconstruction and volumetric analysis of the cerebrovascular tree from CTA data, the classification of vasospasm from DSA data, and the
evaluation of CTP. (A–D) The volumetric evaluation of CTA data. The cerebrovascular tree was virtually reconstructed and a volumetric analysis of the defined vessel
segments was performed. (E,F) Examples of vasospasm scoring. The vessel diameters of the A1 and M1 segments declined by >50%, resulting in vasospasm
scores of 2. (G) Example of CTP with cerebral hypoperfusion (elongated mean transit time, reduced cerebral blood flow) in both anterior cerebral artery territories.
CTA, computed tomography angiography; DSA, digital subtraction angiography; CTP, computed tomography perfusion imaging.
TABLE 1 | Volumetric thresholds that indicate severe vasospasm.
Vessel
segment
Threshold
(µL/mm)
95% CI
(µL/mm)
No. of
examinations/patients*
BA 4.3 [2.8, 10.3] 18/10
PCA 1.0 [0.9, 2.7] 18/10
ICA 9.2 [5.5, 9.8] 19/10
M1 5.0 [4.6, 8.0] 20/10
M2
(frontal
branch)
1.8 [1.0, 4.3] 17/9
M2
(temporal
branch)
3.1 [2.2, 3.9] 20/10
A1 2.7 [1.6, 3.7] 19/10
A2 2.1 [1.6, 4.0] 17/10
*The thresholds were determined using the data for 20 digital subtraction angiography
studies (DSAs) from 10 patients. An evaluation was not possible for every segment in every
DSA, and the fourth column shows the actual numbers of examinations and patients from
which the thresholds were calculated. CI, confidence interval; BA, basilar artery; PCA,
posterior cerebral artery; ICA, internal carotid artery.
individuals (32). The results of the ROC curve analyses to
determine a threshold for each of the defined vessel segments that
indicated severe vasospasm are presented in Table 1.
Diagnostic Value for Predicting Cerebral
Hypoperfusion
The 96 CTAs for which a corresponding CTP was available
included 28 CTPs graded with a score of at least 1, indicating
cerebral hypoperfusion. The corresponding CTAs were subjected
to the volumetric evaluation and diagnostic values were
calculated for the three proposed criteria in which at least one,
two, or three segmental vessel volumes were lower than the
respective thresholds (considered to indicate a pathologic CTA),
with the CTP evaluation considered to be the gold standard. The
most successful criterion for predicting cerebral hypoperfusion
on the corresponding CTP was that at least one vessel segment
had a volume lower than the respective threshold (sensitivity
89%, specificity 41%, NPV 90%, and PPV 39%). The results are
shown in Table 2A.
Diagnostic Value for Predicting
Subsequent Endovascular Vasospasm
Therapy
For the 96 CTAs with corresponding CTP, 19 were associated
with patients who underwent endovascular vasospasm treatment
within the 24 h following the scans. The combination of CTA and
CTP was superior to either CTA or CTP alone for predicting
an impeding infarction requiring endovascular intervention. A
TABLE 2A | Diagnostic value of the volumetric CTA evaluation for diagnosing
cerebral hypoperfusion.
CTP
showing
hypoperfusion
Vasospasm on CTA
≥1 segment ≥2 segments ≥3 segments
N 96 96 96
FP 40 23 9
FN 3 8 11
TP 25 20 17
TN 28 45 59
Sensitivity 89% 71% 61%
Specificity 41% 66% 87%
NPV 90% 85% 84%
PPV 39% 47% 65%
CTA, computed tomography angiography; CTP, computed tomography perfusion
imaging; N, number; FP, false positive; FN, false negative; TP, true positive; TN, true
negative; NPV, negative predictive value; PPV, positive predictive value.
TABLE 2B | Diagnostic values of CTP and volumetric CTA evaluation for
predicting subsequent endovascular vasospasm treatment.
Endovascular
vasospasm
treatment
CTP Vasospasm on CTA
≥1 segment ≥2 segments ≥3 segments
N 96 96 96 96
FP 16 48 27 13
FN 7 2 3 6
TP 12 17 16 13
TN 61 29 50 64
Sensitivity 63% 90% 84% 69%
Specificity 79% 38% 65% 83%
NPV 90% 94% 94% 91%
PPV 43% 26% 37% 50%
CTP, computed tomography perfusion imaging; CTA, computed tomography
angiography; N, number; FP, false positive; FN, false negative; TP, true positive; TN, true
negative; NPV, negative predictive value; PPV, positive predictive value.
CTP showing hypoperfusion in combination with automated
CTA evaluation that detected three or more vasospasms yielded
a sensitivity for predicting an impeding infarction requiring
endovascular intervention of 58%, with specificity 92%, NPV
90%, and PPV 65%. The results are shown in Tables 2B,C.
DISCUSSION
In this study, we retrospectively analyzed CTA data acquired
as part of the diagnostics for DCI for a cohort of consecutive
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TABLE 2C | Diagnostic value of the combination of CTP and volumetric CTA
evaluation for predicting subsequent endovascular vasospasm treatment.
Endovascular
vasospasm
treatment
CTP & CTA
(1 segment)
CTP & CTA
(2 segments)
CTP & CTA
(3 segments)
N 96 96 96
FP 13 8 6
FN 7 7 8
TP 12 12 11
TN 64 69 71
Sensitivity 63% 63% 58%
Specificity 83% 90% 92%
NPV 90% 91% 90%
PPV 48% 60% 65%
CTP, computed tomography perfusion imaging; CTA, computed tomography
angiography; N, number; FP, false positive; FN, false negative; TP, true positive; TN, true
negative; NPV, negative predictive value; PPV, positive predictive value.
SAH patients. We digitally reconstructed the cerebrovascular
tree and performed a volumetric analysis of the arteries of
the circle of Willis and their major branches. By comparison
with DSA, we determined volumetric thresholds for each vessel
segment that indicated severe vasospasm. This resulted in three
main findings: Firstly, the volumetric evaluation of CTA data
allowed automated, investigator-independent detection of severe
vasospasms. Secondly, identifying CTA vasospasm in at least
one vessel segment exhibited a high sensitivity and NPV for
predicting the presence of cerebral hypoperfusion on CTP,
although the specificity and PPV were rather low. Thirdly,
the combination of the automated detection of vasospasm
on CTA and cerebral hypoperfusion on CTP was superior
to assessments by either CTP or CTA alone for identifying
patients with impeding cerebral infarction who underwent
interventional DSA for vasospasm treatment to prevent this
within 24 h.
It remains difficult to identify the patients who would
benefit from endovascular treatment of vasospasm. CTP
has been shown to have good sensitivity and specificity
for predicting angiographic vasospasm or cerebral infarction
in SAH patients during the course of the disease (13–
18); however, a prospective study reported that CTP had
a PPV of only 29% for predicting severe vasospasm or
a new cerebral infarction within the subsequent 72 h (19).
Another study reported that a combination of vasospasm
identified by CTA together with an increased mean transit
time on CTP was the most accurate method for predicting
vasospasm as identified by DSA (20). Therefore, in many
clinical centers (including ours), the decision on whether or
not to perform endovascular vasospasm treatment is based on
the clinical symptoms, combined with CTP to detect cerebral
hypoperfusion and CTA to estimate the extent of angiographic
vasospasm. However, while the CTP evaluation is based on
rather objective parameters and scores (13–19), there is a lack
of corresponding objective parameters for the evaluation of
CTA, resulting in a considerable degree of subjectivity and
investigator dependence.
Digital, volumetric, segmental evaluations of the
cerebrovascular tree can help to detect and quantify vasospasm
in an objective, investigator-independent manner and to
exploit more fully the information from the imaging data.
However, the finding of the present study that the automated
detection of vasospasms on CTA yielded better results when
combined with CTP data indicates the need for integrating
this technique in a diagnostic workflow that involves CTP,
CTA, and all other available sources of relevant information
(such as clinical examinations). This could reduce subjective,
investigator-dependent influences on the identification of
SAH patients who require endovascular therapies. Reducing
subjectivity is also a prerequisite for the design of prospective
clinical studies for investigating the effectiveness of endovascular
vasospasm therapies.
In a notable number of cases, severe vasospasms of at
least one vessel segment were detected without hypoperfusion
on CTP. We also observed cerebral hypoperfusion in the
absence of severe vasospasm in some cases. These observations
were consistent with previous studies, which showed that
vasospasm and cerebral hypoperfusion can occur independently
(30, 33, 34) and that DCI has a multifactorial genesis (4).
Again, this highlights the need for multimodal monitoring of
SAH patients.
This study had several limitations. It involved a retrospective
analysis of the data of a cohort of 40 SAH patients. Although the
evaluation confirmed that the digital volumetric assessment of
CTA data was technically feasible and could detect vasospasms
objectively, these findings reflect the diagnostic and therapeutic
processes of our center and may not be directly transferrable to
other centers. The design of this study did not take dependence
of the data into account. The estimation errors of the diagnostic
values are therefore larger than would be estimated from the
numbers of examinations. Similarly, confidence intervals for
the thresholds are larger than reported in Table 1. For these
reasons, a prospective clinical study is needed to examine the
suitability of the method for clinical application. The volumetric
thresholds determined in this study were not adjusted for
individual differences; however, a recent imaging study reported
that vessel diameters depend on age and sex (35). Differences
associated with sex and age are small compared to those
induced by severe vasospasm; nevertheless, a study with a larger
patient cohort might reveal significantly different thresholds
for severe vasospasm for male and female patients or for
different age groups. Finally, differences in the administration
of the contrast medium, such as timing and dose, or in the
CT scanning protocols and image processing can influence
the volumetric values and defined thresholds in the same way
as occurs with a non-standardized windowing procedure. We
expect these factors to have only a low impact on the results
of this study because all the CTA scans investigated were
acquired and evaluated in a single center according to highly
standardized protocols; nevertheless, this may compromise the
transferability of our results (especially the threshold values) to
other centers.
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